Alacant, Spain. In Aten Primaria, Feb 2016
OBJECTIVES: Define the impact and causes of non-adherent type-2 diabetes mellitus (DM2) patients, possible solutions and the role of the different health care professionals involved in the treatment.
Current challenges in HER2-positive breast cancer.
Udine, Italy. In Crit Rev Oncol Hematol, Dec 2015
Moreover, with the availability of new highly effective HER2-directed therapies, including pertuzumab and trastuzumab-emtansine (T-DM1), the treatment algorithm for HER2-positive breast cancer continues to evolve.